{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:36Z","timestamp":1761900576638,"version":"build-2065373602"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Given the limited evidence on the optimal caspofungin dose for patients with obesity and candidemia, this study aims to evaluate the clinical outcomes of the standard caspofungin dose in critically ill patients with obesity and candidemia. A multicenter, retrospective cohort study was conducted in three tertiary care hospitals in Saudi Arabia. Eligible critically ill patients with confirmed candidemia who received standard dose of caspofungin were stratified according to their Body Mass Index (BMI) at the time of caspofungin initiation into two groups: control (BMI: 18\u201329.9\u00a0kg\/m2) or obese (BMI: \u226530\u00a0kg\/m2). The primary outcome was the incidence of clinical success. All other outcomes were considered secondary. The significance level was set at a P-value of\u00a0&amp;lt;.05, and statistical analysis was conducted using SAS 9.4 software. A total of 108 patients were included; forty-six (42.6%) were obese. There were no significant differences in terms of clinical success between the groups (aOR, 1.38; 95% CI, 0.54\u20133.54; P\u00a0=\u00a0.50). Microbiological success rate was numerically higher in the control group compared to obese patients (83.9% vs. 69.6%; P\u00a0=\u00a0.07); notably, the difference was statistically significant in the regression analysis (aOR, 3.40; 95% CI, 1.040\u201311.099; P\u00a0=\u00a0.04). No significant differences were observed in other outcomes, including time for microbiological success, treatment failure, infection recurrence within 90 days, mortality, and length of stay. In conclusion, patients with obesity had similar clinical success to control group; however, a lower microbiological success rate was observed in patients with obesity. Further research is needed to explore long-term implications of caspofungin therapy in obese patients with candidemia.<\/jats:p>","DOI":"10.1093\/mmy\/myaf093","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:14:04Z","timestamp":1760012044000},"source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of caspofungin for the treatment of candidemia in critically ill patients with obesity: A multicenter retrospective cohort study"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-3666","authenticated-orcid":false,"given":"Aisha","family":"Alharbi","sequence":"first","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA) , Jeddah ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Jeddah ,","place":["Saudi Arabia"]},{"name":"King Saud Bin Abdulaziz University for Health Sciences , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-2043","authenticated-orcid":false,"given":"Khalid","family":"Al\u00a0Sulaiman","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City , Riyadh ,","place":["Saudi Arabia"]},{"name":"College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences , Riyadh ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Riyadh ,","place":["Saudi Arabia"]},{"name":"Saudi Critical Care Pharmacy Research (SCAPE) Platform , Riyadh ,","place":["Saudi Arabia"]},{"name":"Saudi Society for Multidisciplinary Research Development and Education (SCAPE Society) , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Damfu","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA) , Jeddah ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Jeddah ,","place":["Saudi Arabia"]},{"name":"King Saud Bin Abdulaziz University for Health Sciences , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuroug A","family":"Alowais","sequence":"additional","affiliation":[{"name":"College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences , Riyadh ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Riyadh ,","place":["Saudi Arabia"]},{"name":"King Abdulaziz Medical City, National Guard Health Affairs , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences , Riyadh ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Riyadh ,","place":["Saudi Arabia"]},{"name":"Pharmaceutical Care Services, King Salman Specialized Hospital, Ministry of the National Guard-Health Affairs , Taif ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazed Saleh","family":"Alsowaida","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Ha\u2019il , Hail ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal A","family":"Aljohani","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City , Riyadh ,","place":["Saudi Arabia"]},{"name":"College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences , Riyadh ,","place":["Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisrin","family":"Bifari","sequence":"additional","affiliation":[{"name":"Pharmacy Practices Department, College of Pharmacy, Umm Al-Qura University , Makkah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Alshammari","sequence":"additional","affiliation":[{"name":"King Fahad Medical City , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Asiri","sequence":"additional","affiliation":[{"name":"Prince Mansour Military Hospital , Taif ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imtinan A","family":"Almasoudi","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Department, King Saud Medical City, Ministry of Health , Riyadh 12746 ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwah","family":"Almuzaini","sequence":"additional","affiliation":[{"name":"King Salman bin Abdulaziz Medical City, Ministry of Health , Medina ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwaq F","family":"Alqurashi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, Makkah Health Cluster , Makkah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seba K","family":"Alobathani","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Faisal Specialist Hospital & Research Centre , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entisar J","family":"Almodyan","sequence":"additional","affiliation":[{"name":"Hail General Hospital, Hail Health Cluster , Hail ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Almutairy","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Fahad Armed Forces Hospital , Jeddah ,","place":["Saudi Arabia"]},{"name":"Department of Pharmaceutical Sciences, Fakeeh College for Medical Sciences , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Aldhafeeri","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Royal Commission Hospital , Jubial industrial City ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad A","family":"Alshehri","sequence":"additional","affiliation":[{"name":"King Saud Medical City , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiah Sowaid","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA) , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A","family":"Alhammad","sequence":"additional","affiliation":[{"name":"Pharmacy Department, John Hopkins Aramco Healthcare , Dhahran ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atheer Mohammad","family":"Aljuhani","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA) , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah","family":"Alandas","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdulaziz Medical City , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohoud","family":"Aljuhani","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2025103104211923900_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"2025103104211923900_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40560-020-00450-7","article-title":"Impact of host- and early treatment-related factors on mortality in ICU patients with candidemia: A bicentric retrospective observational study","volume":"8","author":"Ohki","year":"2020","journal-title":"J Intensive Care"},{"key":"2025103104211923900_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-2766-1","article-title":"Risk factors for candidemia: a prospective matched case-control study","volume":"24","author":"Poissy","year":"2020","journal-title":"Crit Care"},{"issue":"6 Suppl","key":"2025103104211923900_bib4","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1086\/430923","article-title":"Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies","volume":"41","author":"Wenzel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025103104211923900_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/cc9239","article-title":"Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit","volume":"14","author":"Bassetti","year":"2010","journal-title":"Crit Care"},{"key":"2025103104211923900_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025103104211923900_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jac\/dkm125","article-title":"Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit","volume":"60","author":"Nguyen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2025103104211923900_bib8","article-title":"Cancidas summary of product characteristics"},{"key":"2025103104211923900_bib9","first-page":"e00345","article-title":"Nonstationary pharmacokinetics of caspofungin in ICU patients","volume":"64","author":"De\u00a0Moor","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025103104211923900_bib10","first-page":"e01582","article-title":"Low caspofungin exposure in patients in intensive care units","volume":"61","author":"Van\u00a0Der\u00a0Elst","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025103104211923900_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijantimicag.2017.05.013","article-title":"Guglieri-L\u00f3pez B. Dosing of caspofungin based on a pharmacokinetic\/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration","volume":"51","author":"P\u00e9rez-Pitarch","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl_1","key":"2025103104211923900_bib12","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/jac\/dkx447","article-title":"Overview of antifungal dosing in invasive candidiasis","volume":"73","author":"Pea","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025103104211923900_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.46.3.739-745.2002","article-title":"Single- and multiple-dose pharmacokinetics of caspofungin in healthy men","volume":"46","author":"Stone","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2025103104211923900_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40121-020-00285-7","article-title":"Impact of obesity in patients with Candida bloodstream infections: a retrospective cohort study","volume":"9","author":"Barber","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2025103104211923900_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0885066618767835","article-title":"Invasive candidiasis in critically ill patients: a prospective cohort study in two tertiary care centers","volume":"35","author":"Al-Dorzi","year":"2020","journal-title":"J Intensive Care Med"},{"key":"2025103104211923900_bib16","doi-asserted-by":"crossref","first-page":"e00905","DOI":"10.1128\/AAC.00905-20","article-title":"Caspofungin weight-based dosing supported by a population pharmacokinetic model in critically ill patients","volume":"64","author":"M\u00e4rtson","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"article-title":"Overweight and obesity - symptoms and diagnosis | NHLBI, NIH","year":"2022","author":"NIH","key":"2025103104211923900_bib17"},{"key":"2025103104211923900_bib18","article-title":"Highlights of prescribing information - caspofungin acetate for injection safely and effectively"},{"key":"2025103104211923900_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025103104211923900_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"2025103104211923900_bib21","first-page":"50","article-title":"Hypokalemia","volume":"34","author":"Hirsch","year":"2021","journal-title":"J Am Acad Physician Assist"},{"volume-title":"SAS\/STAT 15.3 User\u2019s Guide","year":"2023","author":"SAS Institute Inc","key":"2025103104211923900_bib22"},{"key":"2025103104211923900_bib23","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2147\/IDR.S462301","article-title":"Impact of obesity on echinocandin effectiveness in treating candida infections: a retrospective observational cohort study","volume":"17","author":"Aljohani","year":"2024","journal-title":"Infect Drug Resist"},{"key":"2025103104211923900_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0897190020938219","article-title":"Influence of body weight category on outcomes in candidemia patients treated with anidulafungin","volume":"35","author":"Hutton","year":"2022","journal-title":"J Pharm Pract"},{"key":"2025103104211923900_bib25","first-page":"748","article-title":"Efficacy and safety of caspofungin in obese patients","volume":"49","author":"Ryan","year":"2011","journal-title":"Med Mycol"},{"key":"2025103104211923900_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ajhp\/zxad021","article-title":"Echinocandin exposures in obese patients: a scoping review and clinical perspectives","volume":"80","author":"Alsowaida","year":"2023","journal-title":"Am J Heal Pharm"},{"key":"2025103104211923900_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2119\/molmed.2016.00211","article-title":"Obesity paradox, obesity orthodox, and the metabolic syndrome: an approach to unity","volume":"22","author":"Roth","year":"2016","journal-title":"Mol Med"},{"key":"2025103104211923900_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/jphp.12780","article-title":"Echinocandins in antifungal pharmacotherapy","volume":"69","author":"Patil","year":"2017","journal-title":"J Pharm Pharmacol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf093\/64612734\/myaf093.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/10\/myaf093\/64612734\/myaf093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/10\/myaf093\/64612734\/myaf093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:21:25Z","timestamp":1761898885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf093\/8280390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf093","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"type":"print","value":"1369-3786"},{"type":"electronic","value":"1460-2709"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,30]]},"article-number":"myaf093"}}